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Abstract
Background: Moyamoya is a rare cerebrovascular disease of unknown etiology. The data on
moyamoya disease from Pakistan is sparse. We report a case series of 13 patients who presented
with moyamoya disease to a tertiary care hospital in Pakistan with a national referral base.
Methods: We conducted a retrospective review of thirteen patients who presented to The Aga
Khan University and diagnosed with "Moyamoya Disease" during the period 1988 – 2006. These
patients were identified from existing hospital database via ICD-9 codes. A predesigned
questionnaire containing information about clinical presentation, management and neuroimaging
was administered to all identified patients.
Results: There were seven males and six females. Mean age at presentation was 16.5 years and a
female predominance was found in the pediatric age group (n = 10, 71.4%). Stroke (n = 11, 84.2%)
was the most common presentation with motor deficit being the universal cortical symptom. Fever
was a common symptom in the lower age groups (n = 4, 51.7%). Cerebral Angiography and
Magnetic Resonance Angiography showed bilateral involvement of the vessels in eleven patients
while unilateral in two. Subarachnoid and interventricular haemorrhage appeared in 2(15.4%)
adults. Twelve (92.3%) patients were discharged as independent with minor deficits regardless of
therapeutic modality. Only three (23.0%) patients underwent surgery whereas the remaining were
managed conservatively.
Conclusion: Physicians when dealing with childhood strokes and characteristic deficits in adult
population should consider Moyamoya disease.

Background
Moyamoya disease is a rare progressive vaso-occlusive disorder of an unknown etiology. It is characterized by progressive stenosis of terminal portions of internal carotid
arteries bilaterally, and the main trunks of Anterior and

Middle Cerebral Artery, and is associated with collateral
vessels at the base of the brain ('moyamoya' vessels).[1]
When similar clinical manifestations are associated with
an underlying disorder, it is refered to as Moyamoya syndrome. However, since the diagnostic criteria of this disPage 1 of 8
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ease are mainly based on angiographic findings, it is
recommended that the term Moyamoya 'syndrome'
should be avoided at best.[2] Previously thought to be
prevalent only in Japan, cases have now been reported
from across the globe.[3,4] However, majority of the cases
are reported in Asia and other non-Caucasian regions. [2].
Moyamoya disease has remained rather unexplored in
Pakistan. So far only one case series of four patients has
been described, while a few case reports exist.[5-7] Since
several studies have reported the occurrence of stroke in
young in this region [8], it could be questioned whether
Moyamoya disease is under-diagnosed in Pakistan.
The patterns of presentation of Moyamoya disease
reported in the literature so far have shown several consistent features, such as hemiparesis, monoparesis or sensory disturbances reflecting TIA in children, or
intracerebral, intraventricular and/or sub-arachnoid
haemorrhage in adults. Whether these particular patterns
of presentation are universal, and if not, what differences
exist from the conventional findings are some of the questions that remain to be answered with respect to this particular disease, The aim of this article is to describe our
clinical experience with Moyamoya disease in a tertiary
care hospital in Pakistan.

Methods
We report 13 patients presenting to The Aga Khan University diagnosed with "Moyamoya Disease" during the
period 1988 – 2006, according to the retrospective search
query in the hospital database. Diagnosis was based on
characteristic radiological findings on Cerebral Angiogram or MRI/MRA. All patients received an MRI and
MRA, and in those whose findings were suggestive but not
clear or those that required further intervention received a
4 vessel cerebral angiogram. The data was collected during
the month of August 2006. A questionnaire containing
fields of demographics, clinical features, imaging, hemodynamic studies, procedures, treatment and follow up was
designed and filled for each case. A MeSH search was conducted on the MEDLINE database using key words
"Moyamoya Disease" [MeSH], "Moyamoya Disease" [MeSH]
AND "Pakistan" [MeSH]. Also, a comprehensive literature
search was performed to assess the differences between
clinical pictures and outcomes of moyamoya disease in
various geographical locations. The local hospital ethical
review committee approved this study.
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was 16.57 years and the age of presentation was the age of
1st symptom in 11 (84.6%) patients. The youngest age
group (0–12 years) comprised only of females.
Table 1 shows the symptomatic checklist and outcomes
for each patient. The clinical presentation included fever,
stroke, headache and seizures. All the patients with sudden onset of stroke (n = 11, 84.6%) had a motor deficit
making it the most common cortical symptom. Blindness
and aphasia were present in 1 patient each. Fever was a
common presentation especially in the lower age groups,
occurring in 4 (30.7%) of the patients. 6 (46.1%) cases
presented with seizures, with one having a generalized
tonic-clonic. 1 (7.7%) patient developed bilateral hemiparesis and seizures while suffering from encephalitis.
None of the patients reported any inherited disorders in
the family. 3 (23.0%) patients were found to suffer from
repeated TIAs as they presented with intermittent weakness.
Past medical history of 1 (7.7%) of the patients revealed
encephalitis following post natal sepsis, while 2 (15.4%)
cases had past neurological history, with one having cognitive deficits and the other being aphasic since birth. 2
(15.4%) of the patients had a history of cardiac defects at
birth, which resolved spontaneously in both the cases. A
40-year-old male who presented with occipital headache
had a history of repeated headaches, for which he was taking analgesics off and on. 1 (7.7%) patient had a post-partum state, having delivered two weeks back. She had a
history of repeated abortions.

Results

MRI and MRA was performed in all cases 7 (53.9%)
patients underwent Cerebral Angiography either at the
time of presentation. Of the 13 patients reported,
11(84.6%) had bilateral involvement of the vessels showing stenosis to complete occlusion on MRA or cerebral
angiograms.(Figure 1) The various sites of occlusion and
stenosis included the supraclinoid portions of ICA, MCA
and ACA at specific segments or at their origins at circle of
willis.(Figure 2) 2 (15.4%) cases showed unilateral
involvement hence falling under the category of 'probable
moyamoya disease'. Cranial CT and MRI showed subarachnoid and interventricular haemorrhage in 2 adults. Of the
remaining 11(84.6%) patients, 4 (30.8%) patients had
multiple corticomedullary infarcts while the rest had a coexisting sub-cortical infarct involving the territory of the
stenosed/occluded vessel-mostly the ACA or/and the
MCA. The classical 'smokey' appearance of moyamoya
vessels was seen only in 4 (30.8%) patients. (Figure 3)

The hospital database revealed 13 patients (7 males and 6
females) admitted over the past 20 years (1986–2006). Of
the 13 patients reported, 7 (53.8%) belonged to the age
group 0–12 yrs, 3 were in the range 13–25, while 3
(23.0%) patients were over 26. Mean age at presentation

EEG was performed in 6 (46.1%) patients. 4 (30.8%)
showed diffuse cerebral dysfunction whereas two (15.4%)
had an epileptiform activity; with one being focal and the
other non-focal.
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Table 1: Patterns of presentation

Patient Age/years Sex Fever Headache Seizure Stroke Hemorrhage Bilateral Repeated
TIAs

Surgery* Outcome

1

6

F

Y

Y

N

Y

N

N

N

N

Dx

2

3.5

M

Y

N

Y

Y

N

Y

N

N

Dx

3

18

M

Y

N

Y

Y

N

Na

N

Y

Dx

4

25

M

Y

Y

N

Y

N

Y

N

N

Died

5

12

M

N

N

N

Y

N

Y

N

N

Dx

6

40

M

N

Y

N

N

Y

Y

N

N

Dx

7

9

F

N

N

Y

Y

N

Y

N

Y

Dx

8

4

F

N

N

N

Y

N

Y

N

Y

Dx

9

40

M

N

Y

N

N

Y

Y

N

N

Dx

10

0.5

F

N

N

Y

Y

N

Y

Y

N

Dx

11

10

F

N

Y

Y

Y

N

Y

Y

N

Dx

12

17

M

N

Y

N

Y

N

Ya

Y

N

Dx

13

30

F

N

Y

Y

Y

N

Y

N

N

Dx

Y: yes; N: No; F: Female; M: Male; Dx: Discharged
*Revascularization surgery
a based on symptoms

Lab investigations, including coagulation profiles were
performed in all cases. Of the thirteen patients in this
study, those that presented with fever and seizures
(6;46.2%) got a lumbar puncture. 4 (66.7%) had a normal CSF, 2 (33.3%) had a moderate rise in proteins showing a level of 70 mg/dl. None had a positive culture.
Ancillary lab results, for most parts, were unremarkable.
None of the patients showed a hypercoagulable state, and
ANA, ASMA, Anti-DSDNA, and Anticardiolipin antibodies were negative in all patients. 1 (7.7%) patient had
mildly elevated Serum Homocysteine levels (12.74,
patient D).



Figure 1 Resonance
Magnetic
suggestive
of Moya Moya
Angiogram
Diseaseshowing bilateral stenosis
Magnetic Resonance Angiogram showing bilateral
stenosis suggestive of Moya Moya Disease.

3 patients underwent surgical procedures. A 9 yr old had
an EC/IC bypass and two patients, aged 18 and 4 underwent EDAS. 1 (7.7%) patient developed an extradural
hematoma right after the procedure which was removed
promptly and the patient improved. All patients were discharged once stable after the procedures.
Of the 10 patients who underwent conservative management. 2 (15.4%) received steroids at the discretion of the
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Figure
Angiogram
MCA
consistent
2 showing
withstenosis
Moya Moya
of theDisease
supraclinoid ICA and
Angiogram showing stenosis of the supraclinoid ICA
and MCA consistent with Moya Moya Disease.

treating physician. Anticonvulsants were given to the
patients who had presented primarily with a seizure or
developed them during hospital stay. Drug levels were
monitored for these patients. Febrile patients were given
antiviral and systemic antibiotics until CSF culture and
Herpes PCR results were received. IV Mannitol was
reserved for patients with deteriorating neurological status
or increased intracranial pressure in the setting of haemorrhage.
12 (92.3%) patients were eventually discharged with
improved GCS and minor neurological deficits. These
included limb weakness, partial aphasia and headaches. 1
(7.7%) adult male had a sudden deterioration of symptoms after bilateral stroke, who expired after a brief coma.

Discussion
For several decades since its discovery by Takeuchi and
Shimizu in 1957 [9], Moyamoya disease was considered
to be mainly confined to certain ethnic groups, particularly the Japanese. As more cases were discovered worldwide, interest into understanding its etiology,
pathogenesis and clinical course also became more profound. So far, approximately 6000 cases of Moyamoya
disease have been reported across the globe, with almost

Figurethe
Cerebral
prises
3 Angiogram
abnormal collaterals
showing the "puff of smoke" that comCerebral Angiogram showing the "puff of smoke"
that comprises the abnormal collaterals.

two-thirds confined to Japan. [9,10] However, a number
of cases from other countries including Korea, China,
India and even the United States have now been added to
the literature.[11-14]
Moyamoya disease is a cerebrovascular pathology, characterized by unilateral or bilateral stenosis or occlusion of
intracranial segment of internal carotid artery (ICA) and
the proximal parts of anterior and middle cerebral arteries. Subsequently, parenchymal, leptomeningeal and
transdural collaterals develop in the ischemic brain as a
response to hypoxia.[15-17] Literally meaning "a puff of
smoke", the name moyamoya disease was coined on the
basis of radiological finding by Suzuki and Takaku [1],
when the abnormal collaterals appeared to give a hazy,
'cigarette smoke' appearance on a cerebral angiogram.
The pathological findings as seen on autopsy cases, irrespective of age, suggest involvement of distal portion of
carotid arteries and the proximal portions of the anterior
and middle cerebral arteries. There is extensive intimal
thickening with tortuous and duplicated internal elastic
lamina of the arteries, and there may also be lipid deposition in the intima. However, an important feature is the
lack of inflammatory signs and atheromatous
plaque.[9,18]
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Etiology of Moyamoya disease is controversial. Even
though several linkage studies have shown promising
relations with gene loci [19,20], no specific locus has yet
been identified. However, these linkage studies, along
with the familial occurrence of Moyamoya, point towards
a probable genetic basis underlying its etiology. Investigations into understanding the pathogenesis of Moyamoya
disease have shown involvement of the CSF basic Fibroblast growth factor (b-FGF) with receptor up-regulation,
and TGF beta 1 in altering the cerebral vasculature.[9,21,22] Intimal thickening has also been postulated resulting from altered permeability owing to
enhanced prostaglandin release from the arterial smooth
muscle.[23]
Our series of thirteen Moyamoya cases is the largest by far
in the country. This small number for a 20 year record at
one of the largest tertiary care hospital in Pakistan suggests
that either the prevalence of Moyamoya disease is low in
the country, or that the disorder is seldom brought to clinical attention. The latter could be supported on the
grounds that Pakistan, like its neighboring regions, is burdened with the wrath of communicable diseases, which
are responsible for the major share of infant and childhood mortality, and hence obscure the actual incidence of
non-communicable diseases. Also, it is possible that a
clinical variant of Moyamoya disease occurs in this region,
which goes by undiagnosed at large.
Our study sample had an almost equal sex distribution, in
contrast to the worldwide literature, which suggests a
slight female preponderance. Due to scanty local data, the
higher occurrence in males in our sample cannot be commented upon conclusively. However, pediatric studies
have proven that the overall risk factor for stroke is greater
in boys compared to girls.[24]
Moyamoya disease is reported to primarily present at an
early age, typically less than 10 years, and is more common in females (M:F 1:1.8). However, a second peak in
the fourth decade has also been described in the literature.[25] Our patients showed a consistent finding, with 7
(54%) of the cases under the age of twelve with male
adults being predominantly affected.
Conditions such as sickle cell anemia, Neurofibromatosis1, Down's syndrome, congenital heart defects, Antiphospholipid syndrome, Renal artery stenosis and thyroiditis
have been found to be associated with Moyamoya disease
in the literature.[26] Our two cases with congenital heart
defects support the view of Lutterman et al., who reports
five patients with congenital heart defects who developed
Moyamoya disease in childhood.[26] It appears from our
review that most of our patients had Moyamoya disease
rather than the syndrome as none had the known associ-

http://www.biomedcentral.com/1471-2377/9/15

ations except for the congenital cardiac defects mentioned
above.
One of our cases had history of cognitive difficulty in
school prior to the presenting episode of stroke. Such an
intellectual decline has been described but usually after
Moyamoya disease is diagnosed.[27] This finding could
point to the fact that in addition to the consequences like
stroke and seizures, this progressive stenotic process even
directly affects intellect in patients.
The clinical features of patients with Moyamoya disease
reflect the anatomic territory of the brain affected by the
diseased vessel. Yamaguchi et al. in the Annual Report for
the special working group of Welfare Ministry for
Moyamoya in 1979 described four major types of
Moyamoya disease according to clinical manifestations;
the hemorrhagic type, the infarction type, TIA type, and
epileptic type; with the first two types being the most common. [28]
In our cases, stroke symptoms outnumbered other presenting complaints. All the females presented with stroke
as the major complaints, while two males who did not
have any symptomatic stroke were found to have intraventricular haemorrhage on CT Scans. This is an inconsistent finding with other Asian studies, which have revealed
greater prevalence of hemorrhagic presentation in females
[29-33]. Apart from stroke, headache was another consistent feature in our series. The pathophysiological mechanism of headaches in patients with Moyamoya disease
remains unclear, but it is presumed to be closely related to
cerebral hypoperfusion because it has been reported that
headaches disappeared after surgery.[34]
An interesting finding in our cases was a post-infectious
presentation of the patients. Hyperthermia induced vasoconstriction has been described to affect luminal diameter
of the carotid artery leading to hypoperfusion.[35] Hyperthermia could have led to compromise of blood flow and
compromise of the functioning collaterals and trigger the
symptoms in four of our cases. No literature exists at
present that has probed the association between raised
body temperature and occurrence of Moyamoya, and
hence the hypothesis so far could only be based on the
aforementioned discussion unless conclusive, controlled
experiments are carried out.
Despite the reported risks associated with conventional
angiography [36], it is still considered the gold standard
for diagnosing Moyamoya disease. Magnetic resonance
imaging was the most common technique used in our
cases. MRA proved to be a helpful diagnostic tool identifying sites of stenosis and demonstrating the collateral
vessels at the base of the brain. As a non-invasive proce-
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dure, it has been described in the literature as a promising
alternative to classical angiography for this arterial disease. [37] Combined with MRI, it gives information about
brain parenchyma and hence provides a better correlation
of the symptoms with the radiological findings. However,
it overestimates occlusion and underestimates presence of
collaterals and can lead to higher staging of patients and
lead to surgical interventions.[1] Cerebral Angiography
remains the gold standard for these patients.

for service tertiary care centre. These decisions were made
not purely on a scientific basis, individual affordability,
practicing surgeons comfort level and expertise with procedure all played into the treatment decisions. In general,
intervention for moya moya is offered as the last resort
and is often an indirect vascularization. Expertise for
direct vascularization is not available in Pakistan – these
procedures are performed with visiting neurosurgeons
from other countries, if at all.

Irrespective of the radiological method used for diagnosis,
conditions like von Recklinghausen's disease, Down's
syndrome, autoimmune vasculitis, head trauma, meningitis and brain tumors may have a similar angiographic
picture and hence can possibly confuse the diagnosis.
Also, postpartum cerebral angiopathy and inflammatory
angiopathy are two important differential diagnoses that
may present with cerebral ischemia and imaging consistent with intracranial vasculopathy mimicking Moyamoya
disease.[38,39]

Surgery results in decreased incidence of TIAs and major
complete strokes in the patients. However, severe stroke
preoperatively proves to be a poor prognostic factor for
the outcomes of the procedure.[44] Potential risks include
complications in handling the thin cortical vessels, postoperative haemorrhage from the neovascular channels
and a delay or even failure of effective resupply of
blood.[20,45]

Yamashiro describes three important patterns of EEG in
Moyamoya patients- a slow wave pattern, localized slow
waves and temporary but prominent "build ups" that are
high voltage delta bursts secondary to hyperventilation.[40] However, we did not find these specific patterns
in our patients. They either had theta or delta slowing or
evidence of epileptiform activity secondary to focal
ischemia. This lack of characteristic EEG findings in our
patients could contribute to the disagreement with Yamashiro's hypothesis of EEG as a screening tool for this disease. However, it should be remembered that our case
patterns are not completely comparable to those in Japan
because of supposed differences in hereditary patterns.
Revascularization procedures are currently performed to
increase the perfusion to the hypoxic brain tissue. The literature supports these procedures and long-term favorable outcome has been reported in terms of improvement
in symptoms and positive angiographic follow-ups in all
age groups.[12,41,42] Four types of surgical procedures
have been described-indirect procedures including
encephalo-duro-arterio-myo-synangiosis
(EDAMS),
direct revascularization via the superficial temporal artery
and the middle cerebral artery (STA-MCA) bypass, combined approaches and rarely, denervation of cerebral vasculature. In general, pediatric cases benefit from indirect
revascularization procedures and the direct bypass is useful in most of adult cases.[43] Our series demonstrates a
successful direct procedure on a child and EDAMS on a
child and an adult case. More patients could have benefited from revascularization procedures to alleviate the
symptoms but cost and loss to follow-up were major barriers in our setting. It is difficult to comment on specific
rationales for strategy in each case since the setting is a fee

Prognosis of patients with Moyamoya disease is found to
be related to age and the type of presentation. Kim et al
have demonstrated less favorable outcome in younger age
groups (< 3 yrs) with severe presentations and increased
incidence of preoperative strokes.[46] However, hemodynamic improvement after surgical procedures appears to
be similar in all age groups. TIA and epileptiform clinical
pictures have a better long-term outcome when compared
to infarctions.[20] In pediatric patients, the TIA groups
have shown better outcomes in terms of school performance, higher IQs and lesser incidence of severe disabilities.
The immediate outcome for our series was reasonably
good. All patients save one had total or near total recovery, and those who underwent surgery also had positive
post operative follow ups. However, due to the lack of
longitudinal data, the functional outcomes of all these
patients cannot be commented upon with certainty.
Moyamoya disease, although a rare disorder in the Pakistani population, is probably underdiagnosed. Diagnosis
requires expensive radiological studies and trained neurophysicians that are not available in most parts of the country. Additionally, the lack of neurosurgeons and their
expertise in highly sophisticated procedures involved in
the treatment makes it further difficult to manage
patients.

Conclusion
Stroke symptoms were frequently noticed in Moyamoya
patients, most of the presenting features were compatible
with reports from other geographic regions with few
exceptions. Only 13 patients presented in 20 years at a tertiary care hospital in Pakistan, which indicates that either
the prevalence of Moyamoya is very low in this region, or
the disorder is seldom brought to medical attention. This
emphasizes the need to consider Moyamoya disease in

Page 6 of 8
(page number not for citation purposes)

BMC Neurology 2009, 9:15

young patients and children presenting with stroke symptoms.
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